Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in Botswana

Background: A large-scale evaluation of mother-to-child transmission (MTCT) with dolutegravir (DTG)-based antiretroviral treatment (ART) has not been conducted previously. Setting: Botswana was the first African country to change from efavirenz (EFV)/tenofovir (TDF)/emtricitabine (FTC) to DTG/TDF/FTC first-line ART. Methods: From April 2015 to July 2018, the Early Infant Treatment Study offered HIV DNA testing at
Source: JAIDS Journal of Acquired Immune Deficiency Syndromes - Category: Infectious Diseases Tags: Rapid Communication Source Type: research